Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

94.80p
   
  • Change Today:
      0.30p
  • 52 Week High: 121.60
  • 52 Week Low: 91.40
  • Currency: UK Pounds
  • Shares Issued: 539.79m
  • Volume: 1,608,529
  • Market Cap: £511.72m
  • RiskGrade: 119

Alliance Pharma Overview

Our Vision is to be a leading international healthcare business, built around products that are clinically valuable to patients.

1 Day Chart (17-08-2022)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 1.8% 1.8%
Div Cover 3.8 3.8
Op Mrgn 13.2% 23.2%
ROCE 46.4%  
Latest F'cast
P/E 14.8 14.6
PEG 0.6 15.1
Pr/Revenue 3.1 2.7
Pr/Book 1.8  
Latest F'cast
Revenue 25.7% 16.0%
PBT 39.5% 141.7%
EPS 25.0% 1.0%
DPS 5.0% 1.4%

Alliance Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 101.64 28.29 5.33p 12.6 0.3 +38% 1.33p 2.0%
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%
31-Dec-20 129.80 13.02 5.11p 17.1 n/a 0% 1.61p 1.8%
31-Dec-21 163.21 18.16 6.39p 17.0 0.7 +25% 1.69p 1.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 189.36 43.89 6.45p 14.7 15.2 +1% 1.72p 1.8%
31-Dec-23 207.78 49.61 6.96p 13.6 1.7 +8% 1.81p 1.9%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Notification of Major Holdings 17-Aug-2022 13:21 RNS
Notification of Major Holdings 17-Aug-2022 07:00 RNS
Change of Auditor 08-Aug-2022 07:00 RNS

Alliance Pharma ShareCast News

Alliance Pharma shares slide following challengi... 20-Jul-2022 ShareCast
Alliance Pharma in 'good health' amid strong dem... 18-May-2022 ShareCast
Alliance Pharma upbeat on prospects for US acqui... 25-Mar-2022 ShareCast

Alliance Pharma Top Newspaper Links

Drug sales lead the way for Boots as revenues ri... 31-Oct-2008 The Scotsman
Look ahead 13-Sep-2006 Times
Look ahead 12-May-2006 Times

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 94.80p
Change Today 0.30p
% Change 0.32 %
52 Week High 121.60
52 Week Low 91.40
Volume 1,608,529
Shares Issued 539.79m
Market Cap £511.72m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
88.76% below the market average88.76% below the market average88.76% below the market average88.76% below the market average88.76% below the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average
Price Trend
15.99% above the market average15.99% above the market average15.99% above the market average15.99% above the market average15.99% above the market average
71.88% above the sector average71.88% above the sector average71.88% above the sector average71.88% above the sector average71.88% above the sector average
Income
53.01% below the market average53.01% below the market average53.01% below the market average53.01% below the market average53.01% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
5.15% above the market average5.15% above the market average5.15% above the market average5.15% above the market average5.15% above the market average
17.95% above the sector average17.95% above the sector average17.95% above the sector average17.95% above the sector average17.95% above the sector average

What The Brokers Say

Strong Buy 5
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 09-Jun-22 16-Dec-21
Paid 07-Jul-22 07-Jan-22
Amount 1.13p 0.56p

Trades for 17-Aug-2022

Time Volume / Share Price
17:11 1,143 @ 94.70p
16:38 35,000 @ 94.74p
16:38 35,000 @ 94.74p
16:35 1,987 @ 94.80p
16:35 83,787 @ 94.80p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page